세계의 임상 의사결정 지원 시스템 시장 보고서(2025년)
Clinical Decision Support Systems Global Market Report 2025
상품코드 : 1824520
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

임상 의사결정 지원 시스템 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 13.0%를 나타내 57억 2,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 정밀의료에 대한 노력, 가치 기반 케어 모델, 실시간 의사결정 지원, 집단 건강 관리, 상호 운용성에 대한 노력, 사이버 보안에 대한 우려에 기인합니다. 예측 기간의 주요 동향에는 모바일 및 클라우드 기반의 CAS 솔루션, 임상 워크플로 최적화, 환자 중심의 CAS 용도, 임상 인사이트를 위한 실시간 분석, 원격 의료 서비스와의 협력 등이 있습니다.

향후 5년간의 성장률 13.0%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국 간의 관세의 영향 때문입니다. 무역 마찰은 이스라엘과 네덜란드에서 개발된 인공지능(AI) 탑재 진단 알고리즘과 약물 상호작용 데이터베이스의 가격을 상승시켜 의사결정의 정확성 저하와 전자 의료 기록(EHR) 통합 비용의 상승을 초래하여 미국의 환자 안전을 저해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

병원에서의 정보시스템 도입의 확대는 향후 임상 의사결정 지원 시스템 시장 성장을 견인할 것으로 예측됩니다. 정보 시스템에는 데이터를 수집, 저장 및 처리하는 데 사용되는 소프트웨어 및 하드웨어가 포함됩니다. 건강 관리 시설은 원활한 운영과 원활한 임상 데이터 흐름을 보장하기 위해 이러한 시스템을 도입하고 있습니다. 예를 들어, 2023년 2월 영국에 본사를 두고 있는 기업 Rock Health는 2022년 조사에서 응답자의 80%가 생활 어딘가에서 원격 의료를 이용한 적이 있다고 보고했고 2021년의 72%에서 8포인트 상승했습니다. 게다가 라이브 비디오 원격 의료의 이용은 2022년에도 일관되었으며, 2021년에 비해 1포인트의 약간 증가에 그쳤습니다. 따라서 병원에 의한 정보시스템 도입 증가는 임상 의사결정 지원 시스템 시장 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Clinical decision support systems (CDSS) are computer programs that evaluate data within electronic health records (EHRs) to offer healthcare providers reminders that help them implement evidence-based clinical guidelines at the point of care.

Clinical decision support systems encompass key components such as services, software, and hardware. They come in different models, including knowledge-based and non-knowledge-based CDSS, utilizing various delivery modes such as on-premise and cloud-based systems. On-premise CDSS operates within an enterprise's internal IT infrastructure, specifically utilized in-house. This software is installed and functions on computers within the organization's premises, facilitating medical diagnoses, alerts, reminders, prescription decision support, information retrieval, and other applications prevalent in clinics, hospitals, ambulatory surgical centers, and similar end-user environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The clinical decision support systems market research report is one of a series of new reports from The Business Research Company that provides clinical decision support systems market statistics, including clinical decision support systems industry global market size, regional shares, competitors with a clinical decision support systems market share, detailed clinical decision support systems market segments, market trends and opportunities, and any further data you may need to thrive in the clinical decision support systems industry. This clinical decision support systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical decision support systems market size has grown rapidly in recent years. It will grow from $3.14 billion in 2024 to $3.51 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increased healthcare data, advancements in medical knowledge, patient safety concerns, healthcare cost pressures, demand for evidence-based medicine.

The clinical decision support systems market size is expected to see rapid growth in the next few years. It will grow to $5.72 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to precision medicine initiatives, value-based care models, real-time decision support, population health management, interoperability initiatives, cybersecurity concerns. Major trends in the forecast period include mobile and cloud-based cuss solutions, clinical workflow optimization, patient-centric cuss applications, real-time analytics for clinical insights, collaboration with telehealth services.

The forecast of 13.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. patient safety by inflating prices of Artificial Intelligence (AI)-powered diagnostic algorithms and drug interaction databases developed in Israel and the Netherlands, resulting in reduced decision-making accuracy and higher Electronic Health Record(EHR) integration costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing adoption of information systems by hospitals is anticipated to drive the growth of the clinical decision support systems market in the future. Information systems encompass the software and hardware used to collect, store, and process data. Healthcare facilities are implementing these systems to ensure smooth operations and seamless clinical data flow. For example, in February 2023, Rock Health, a UK-based corporation, reported in its 2022 survey that 80% of respondents had used telemedicine at some point in their lives, marking an 8-percentage point increase from 72% in 2021. Additionally, the use of live video telemedicine remained consistent in 2022, with only a slight increase of 1 percentage point compared to 2021. Therefore, the rise in information systems adoption by hospitals is fostering growth in the clinical decision support systems market.

The surge in demand for cloud computing is poised to significantly propel the expansion of the clinical decision support systems (CDSS) market. Cloud computing, a technology facilitating the delivery of diverse computing services over the internet, is extensively employed by organizations and individuals to oversee and invest in physical hardware and software infrastructure. Within CDSS, cloud computing plays a pivotal role, enabling healthcare entities to securely store extensive volumes of patient data, medical records, and pertinent information on centralized cloud servers. For example, as per Google LLC, a US-based technology company, in January 2023, the utilization of the public cloud witnessed a notable ascent, with 76% of individuals leveraging this technology in 2022, marking a 56% increase from the preceding year. Hence, the escalating demand for cloud computing stands as a driving force behind the burgeoning growth of the clinical decision support systems market.

Advancements in technology have emerged as the predominant trend driving traction within the clinical decision support systems market. Key players within this sector are directing their efforts toward innovating and introducing novel technological solutions to bolster their market standing. For instance, in April 2022, Change Healthcare, a prominent US-based healthcare technology company, unveiled InterQual, a clinical decision support solution geared toward evidence-based care. This offering incorporates interactive and revamped criteria aimed at optimizing workflow efficiency, along with the integration of artificial intelligence to facilitate proactive insights. Notably, this technology has the capability to predict whether a patient necessitates observation, or whether their condition warrants a short-term or long-term stay, showcasing the strides made in predictive capabilities within clinical decision support systems.

Leading companies in the clinical decision support systems market are concentrating on launching advanced solutions, such as insulin dosing software, to secure a competitive advantage. Insulin dosing software is a specialized clinical decision support system designed to aid healthcare providers in calculating and administering the correct insulin dosages for patients, ensuring personalized and safe glycemic management. For example, in April 2023, Glytec, a US-based platform, released the latest version of its Glucommander insulin dosing platform. Glucommander is a cloud-based insulin dosing software developed by Glytec that offers personalized intravenous (IV) and subcutaneous (SubQ) insulin dosing for patients, irrespective of their diabetes status. It integrates with electronic health record (EHR) systems to enhance clinical workflows and improve patient safety in glycemic management.

In October 2024, VitalHub Corp., a US-based healthcare technology company, acquired MedCurrent Corporation for an undisclosed amount. This acquisition is part of VitalHub's strategy to integrate advanced technology solutions to improve healthcare delivery. MedCurrent Corporation, also a US-based healthcare technology firm, specializes in providing clinical decision support.

Major companies operating in the clinical decision support systems market include McKesson Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Hera-MI LLC, Cerner Corporation, Epic Systems Corporation, Elsevier B.V., Change Healthcare Corporation, Allscripts Healthcare Solutions Inc., Athenahealth Inc., Wolters Kluwer Health, Premier Inc., eClinicalWorks Inc., Veradigm Inc., NextGen Healthcare Inc., Medical Information Technology Inc., Meditech Systems Network Inc., Health Catalyst, CareCloud Inc., CureMD Inc., Strata Decision Technology, Zynx Health, First Databank Inc., Clinical Architecture Inc., VisualDx Group Inc., Apervita Inc., IBM Watson Health, The Medical Algorithms Company LP, RAMPmedical Inc.

North America was the largest region in the clinical decision support systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical decision support systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical decision support systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical decision support systems (CDSS) market consists of sales of knowledge based CDSS, and non knowledge-based CDSS. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Decision Support Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical decision support systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for clinical decision support systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical decision support systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Clinical Decision Support Systems Market Characteristics

3. Clinical Decision Support Systems Market Trends And Strategies

4. Clinical Decision Support Systems Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Clinical Decision Support Systems Growth Analysis And Strategic Analysis Framework

6. Clinical Decision Support Systems Market Segmentation

7. Clinical Decision Support Systems Market Regional And Country Analysis

8. Asia-Pacific Clinical Decision Support Systems Market

9. China Clinical Decision Support Systems Market

10. India Clinical Decision Support Systems Market

11. Japan Clinical Decision Support Systems Market

12. Australia Clinical Decision Support Systems Market

13. Indonesia Clinical Decision Support Systems Market

14. South Korea Clinical Decision Support Systems Market

15. Western Europe Clinical Decision Support Systems Market

16. UK Clinical Decision Support Systems Market

17. Germany Clinical Decision Support Systems Market

18. France Clinical Decision Support Systems Market

19. Italy Clinical Decision Support Systems Market

20. Spain Clinical Decision Support Systems Market

21. Eastern Europe Clinical Decision Support Systems Market

22. Russia Clinical Decision Support Systems Market

23. North America Clinical Decision Support Systems Market

24. USA Clinical Decision Support Systems Market

25. Canada Clinical Decision Support Systems Market

26. South America Clinical Decision Support Systems Market

27. Brazil Clinical Decision Support Systems Market

28. Middle East Clinical Decision Support Systems Market

29. Africa Clinical Decision Support Systems Market

30. Clinical Decision Support Systems Market Competitive Landscape And Company Profiles

31. Clinical Decision Support Systems Market Other Major And Innovative Companies

32. Global Clinical Decision Support Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Decision Support Systems Market

34. Recent Developments In The Clinical Decision Support Systems Market

35. Clinical Decision Support Systems Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기